发明名称 |
USE OF B-TYPE BOTULINUS TOXIN FOLLOWED BY A-TYPE BOTULINUS TOXIN FOR TREATING DYSTONIA |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a method for obtaining a treatment effect even after clinical response for administration of an A-type botulinus toxin has decreased in treatment of neuromuscular disease. Ž<P>SOLUTION: An effective treatment amount of the A-type botulinus toxin is administrated until a patient experiences a decrease in clinical response for its administration, and thereafter an effective treatment amount of a B-type botulinus toxin is administrated to the patient so that neuromuscular disease is treated. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
|
申请公布号 |
JP2010111703(A) |
申请公布日期 |
2010.05.20 |
申请号 |
JP20100013371 |
申请日期 |
2010.01.25 |
申请人 |
ALLERGAN INC |
发明人 |
AOKI K ROGER;GRAYSTON MICHAEL W;CARLSON STEVEN R;LEON JUDITH M |
分类号 |
A61K38/00;A61K35/74;A61K38/16;A61K38/48;A61P21/00;A61P21/02;A61P25/00;A61P25/02;A61P43/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|